Madison, Wisconsin / USA - April 24th, 2020: Nurses at Reopen Wisconsin Protesting against the protesters protesting safer at home order rally holding signs telling people to go home.

Great Responsibility: Navigating Moral Hazards During COVID-19

By Jacqueline Salwa

Younger people may be driving the COVID-19 pandemic in part because they perceive the costs of complying with public health measures as higher and the expected benefits as lower compared with older individuals.

”Indemnifying Precaution: Economic Insights for Regulation of a Highly Infectious Disease,” a paper recently published in the Journal of Law and the Biosciences, explores how to align costs and benefits so that individuals of all ages adhere to precautions.

Younger people tend to experience less severe symptoms from COVID-19 infection, and may be disproportionately affected by other aspects of the pandemic.  These include depression from lack of social interaction, stifled career advancement, and difficulties with providing for dependents.  Compared to younger people, older people have a greater chance of being settled down, retired, and not responsible for dependents. As a result, those that  receive the least benefit from taking precautions, and incur the greatest personal costs for abiding by these precautions, have a lack of incentive to follow precautionary public health measures. This is known, in economic terms, as a moral hazard.

Read More

Journal of Law and the Biosciences Continues to Have an Impact

The COVID-19 pandemic has underscored the importance of the biosciences in our world, as well as the legal, ethical, and regulatory choices that shape the development and implementation of innovations from the biosciences.

The Journal of Law and the Biosciences (JLB) offers high-quality, open-access scholarship at the intersection of the biosciences and law as the first fully open-access, peer-reviewed, legal journal to focus on these issues.

Recently, the Journal of Law and the Biosciences received an updated impact factor of 2.275, highlighting its relevance and influence in law, medicine, and ethics. JLB ranks 25th out of 154 law journals, second of sixteen legal medicine journals, and third out of sixteen medical ethics journals.

Read More

Special Pandemic Issue of the Journal of Law and the Biosciences

On March 24, 2020, the Journal of Law and the Biosciences, jointly run by Duke UniversityHarvard University Law School, and Stanford University, put out a call for essays and articles on governance in a time of pandemic. Between April 22 and May 28, it published 25 articles, all of which are available at the Journal’s website free of charge. We expect that more than 20 additional pieces will join them over the next month or so. The following is a regularly updated list, organized by date and time of publication, of what has been published in that special issue to date.

Read More

New Virtual Issue of Journal of Law and the Biosciences: Editors’ Choice 2020

In this virtual issue from Journal of Law and the Biosciences, we present 17 informative articles, published in 2017-2019, hand-picked by the journal’s three Editors-in-Chief: Nita Farahany from Duke University, Hank Greely from Stanford University, and Glenn Cohen from Harvard Law School.

This specially curated article collection examines a range of matters focusing on the intersection of law and the biosciences, including whether a complete ban on surrogacy is compatible with the American Convention on Human Rights, what role should law play when genetic privacy is concerned, or what opportunities and challenges there are for forensic psychiatry regarding brain-based mind reading.

In selecting articles for this virtual issue, the Editorial Board aims to emphasize the high-quality studies published in Journal of Law and the Biosciences and hopes these will stimulate further research in this new important field.

Check out the full collection!

Photograph of colorful academic journals on a library shelf

Making an Impact: Journal of Law and the Biosciences Scores High

The Journal of Law and the Biosciences is the first fully open-access, peer-reviewed, legal journal focused on the advances at the intersection of law and the biosciences. JLB is co-edited by Profs. I. Glenn Cohen (Harvard Law School), Nita Farahany (Duke University School of Law), and Hank Greely (Stanford Law School). JLB contains original and response articles, essays, and commentaries on a wide range of topics, including bioethics, neuroethics, genetics, reproductive technologies, stem cells, enhancement, patent law, and food and drug regulation. JLB is published as one volume with three issues per year, with new articles posted online on an ongoing basis.

The Journal of Law and the Biosciences recently received a journal impact factor of 2.431, making it one of the most cited, influential journals in its fields. In fact, JLB ranks 14 out of 148 law journals and is ranked third out of sixteen in the areas of both medical ethics and legal medicine.

Read More